JP2013513387A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013513387A5 JP2013513387A5 JP2012543298A JP2012543298A JP2013513387A5 JP 2013513387 A5 JP2013513387 A5 JP 2013513387A5 JP 2012543298 A JP2012543298 A JP 2012543298A JP 2012543298 A JP2012543298 A JP 2012543298A JP 2013513387 A5 JP2013513387 A5 JP 2013513387A5
- Authority
- JP
- Japan
- Prior art keywords
- classification
- mir
- mcp
- data set
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 56
- 239000012472 biological sample Substances 0.000 claims 16
- 229940079593 drug Drugs 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 14
- 239000012474 protein marker Substances 0.000 claims 14
- 230000036541 health Effects 0.000 claims 13
- 201000001320 Atherosclerosis Diseases 0.000 claims 11
- 230000007211 cardiovascular event Effects 0.000 claims 10
- 238000011282 treatment Methods 0.000 claims 10
- 102100021936 C-C motif chemokine 27 Human genes 0.000 claims 9
- 101710112538 C-C motif chemokine 27 Proteins 0.000 claims 9
- 101000880339 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) Sterigmatocystin biosynthesis fatty acid synthase subunit alpha Proteins 0.000 claims 9
- 102100023688 Eotaxin Human genes 0.000 claims 9
- 101710139422 Eotaxin Proteins 0.000 claims 9
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims 9
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims 9
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims 9
- 102000049772 Interleukin-16 Human genes 0.000 claims 9
- 101800003050 Interleukin-16 Proteins 0.000 claims 9
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims 9
- 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims 9
- 108091070501 miRNA Proteins 0.000 claims 9
- 239000002679 microRNA Substances 0.000 claims 9
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims 8
- 101710155834 C-C motif chemokine 7 Proteins 0.000 claims 8
- 101710155833 C-C motif chemokine 8 Proteins 0.000 claims 8
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims 8
- 102000003810 Interleukin-18 Human genes 0.000 claims 8
- 108090000171 Interleukin-18 Proteins 0.000 claims 8
- 108091028066 Mir-126 Proteins 0.000 claims 8
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims 8
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims 8
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 8
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 8
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims 8
- -1 miR-331.3p Proteins 0.000 claims 8
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 claims 8
- 238000013442 quality metrics Methods 0.000 claims 8
- 238000004422 calculation algorithm Methods 0.000 claims 7
- 230000002526 effect on cardiovascular system Effects 0.000 claims 7
- 108091064399 miR-10b stem-loop Proteins 0.000 claims 7
- 102000011690 Adiponectin Human genes 0.000 claims 6
- 108010076365 Adiponectin Proteins 0.000 claims 6
- 102100034608 Angiopoietin-2 Human genes 0.000 claims 6
- 108010048036 Angiopoietin-2 Proteins 0.000 claims 6
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 6
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims 6
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims 6
- 101710098275 C-X-C motif chemokine 10 Proteins 0.000 claims 6
- 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 claims 6
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 6
- 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 claims 6
- 102000016267 Leptin Human genes 0.000 claims 6
- 108010092277 Leptin Proteins 0.000 claims 6
- 102000034655 MIF Human genes 0.000 claims 6
- 108060004872 MIF Proteins 0.000 claims 6
- 102100024289 Metalloproteinase inhibitor 4 Human genes 0.000 claims 6
- 108050006579 Metalloproteinase inhibitor 4 Proteins 0.000 claims 6
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims 6
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 claims 6
- 108700012411 TNFSF10 Proteins 0.000 claims 6
- 238000004458 analytical method Methods 0.000 claims 6
- 108091006374 cAMP receptor proteins Proteins 0.000 claims 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 6
- 239000002299 complementary DNA Substances 0.000 claims 6
- 238000001514 detection method Methods 0.000 claims 6
- 238000009396 hybridization Methods 0.000 claims 6
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 6
- 229940039781 leptin Drugs 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 238000003556 assay Methods 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 5
- 102100034343 Integrase Human genes 0.000 claims 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims 4
- 206010012601 diabetes mellitus Diseases 0.000 claims 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims 4
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 4
- 208000010125 myocardial infarction Diseases 0.000 claims 4
- 238000003752 polymerase chain reaction Methods 0.000 claims 4
- 230000000391 smoking effect Effects 0.000 claims 4
- 108010010234 HDL Lipoproteins Proteins 0.000 claims 3
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims 3
- 206010020772 Hypertension Diseases 0.000 claims 3
- 108091062170 Mir-22 Proteins 0.000 claims 3
- 108091028049 Mir-221 microRNA Proteins 0.000 claims 3
- 230000036996 cardiovascular health Effects 0.000 claims 3
- 108091007423 let-7b Proteins 0.000 claims 3
- 108091031326 miR-15b stem-loop Proteins 0.000 claims 3
- 108091050874 miR-19a stem-loop Proteins 0.000 claims 3
- 108091086850 miR-19a-1 stem-loop Proteins 0.000 claims 3
- 108091088468 miR-19a-2 stem-loop Proteins 0.000 claims 3
- 108091062762 miR-21 stem-loop Proteins 0.000 claims 3
- 108091041631 miR-21-1 stem-loop Proteins 0.000 claims 3
- 108091044442 miR-21-2 stem-loop Proteins 0.000 claims 3
- 108091080321 miR-222 stem-loop Proteins 0.000 claims 3
- 108091092825 miR-24 stem-loop Proteins 0.000 claims 3
- 108091032978 miR-24-3 stem-loop Proteins 0.000 claims 3
- 108091064025 miR-24-4 stem-loop Proteins 0.000 claims 3
- 108091088477 miR-29a stem-loop Proteins 0.000 claims 3
- 108091029716 miR-29a-1 stem-loop Proteins 0.000 claims 3
- 108091092089 miR-29a-2 stem-loop Proteins 0.000 claims 3
- 108091066559 miR-29a-3 stem-loop Proteins 0.000 claims 3
- 108091043187 miR-30a stem-loop Proteins 0.000 claims 3
- 108091063344 miR-30b stem-loop Proteins 0.000 claims 3
- 108091027983 miR-378-1 stem-loop Proteins 0.000 claims 3
- 108091089716 miR-378-2 stem-loop Proteins 0.000 claims 3
- 108091063340 miR-497 stem-loop Proteins 0.000 claims 3
- 108091050734 miR-652 stem-loop Proteins 0.000 claims 3
- 108091034121 miR-92a stem-loop Proteins 0.000 claims 3
- 108091041519 miR-92a-3 stem-loop Proteins 0.000 claims 3
- 108091076732 miR-99a stem-loop Proteins 0.000 claims 3
- 108091064318 miR-99a-1 stem-loop Proteins 0.000 claims 3
- 108091086202 miR-99a-2 stem-loop Proteins 0.000 claims 3
- 238000002493 microarray Methods 0.000 claims 3
- 230000035488 systolic blood pressure Effects 0.000 claims 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- 241000208125 Nicotiana Species 0.000 claims 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 2
- 238000009739 binding Methods 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 238000007398 colorimetric assay Methods 0.000 claims 2
- 210000004351 coronary vessel Anatomy 0.000 claims 2
- 230000008030 elimination Effects 0.000 claims 2
- 238000003379 elimination reaction Methods 0.000 claims 2
- 238000000684 flow cytometry Methods 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000014509 gene expression Effects 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 108091047189 miR-29c stem-loop Proteins 0.000 claims 2
- 108091054490 miR-29c-2 stem-loop Proteins 0.000 claims 2
- 238000002966 oligonucleotide array Methods 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 238000003498 protein array Methods 0.000 claims 2
- 235000002020 sage Nutrition 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 238000012163 sequencing technique Methods 0.000 claims 2
- 238000012706 support-vector machine Methods 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 206010002388 Angina unstable Diseases 0.000 claims 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 108010023302 HDL Cholesterol Proteins 0.000 claims 1
- 102100023915 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 108091007419 MiR-27 Proteins 0.000 claims 1
- 102000007156 Resistin Human genes 0.000 claims 1
- 108010047909 Resistin Proteins 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 208000035868 Vascular inflammations Diseases 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 239000003529 anticholesteremic agent Substances 0.000 claims 1
- 238000003491 array Methods 0.000 claims 1
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 239000002876 beta blocker Substances 0.000 claims 1
- 229940097320 beta blocking agent Drugs 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 239000000480 calcium channel blocker Substances 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000010195 expression analysis Methods 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 210000004251 human milk Anatomy 0.000 claims 1
- 235000020256 human milk Nutrition 0.000 claims 1
- 239000005555 hypertensive agent Substances 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 1
- 238000007477 logistic regression Methods 0.000 claims 1
- 238000010801 machine learning Methods 0.000 claims 1
- 108091049966 miR-27 stem-loop Proteins 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 238000007637 random forest analysis Methods 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 238000012360 testing method Methods 0.000 claims 1
- 230000004797 therapeutic response Effects 0.000 claims 1
- 238000011269 treatment regimen Methods 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 208000019553 vascular disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28512109P | 2009-12-09 | 2009-12-09 | |
| US61/285,121 | 2009-12-09 | ||
| PCT/US2010/059781 WO2011072177A2 (en) | 2009-12-09 | 2010-12-09 | Biomarker assay for diagnosis and classification of cardiovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013513387A JP2013513387A (ja) | 2013-04-22 |
| JP2013513387A5 true JP2013513387A5 (enExample) | 2014-02-13 |
Family
ID=43587661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012543298A Pending JP2013513387A (ja) | 2009-12-09 | 2010-12-09 | 循環器疾患の診断と分類のためのバイオマーカーアッセイ |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20110144914A1 (enExample) |
| EP (1) | EP2510116A2 (enExample) |
| JP (1) | JP2013513387A (enExample) |
| CN (1) | CN102762743A (enExample) |
| AU (1) | AU2010328019A1 (enExample) |
| CA (1) | CA2783536A1 (enExample) |
| WO (1) | WO2011072177A2 (enExample) |
Families Citing this family (129)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| WO2011056186A1 (en) * | 2009-10-26 | 2011-05-12 | Albert Einstein College Of Medicine Of Yeshiva University | Microrna affinity assay and uses thereof |
| EP2865765B1 (en) * | 2010-04-20 | 2016-08-17 | Hummingbird Diagnostics GmbH | Complex miRNA sets as novel biomarkers for an acute coronary syndrome |
| US20130171649A1 (en) * | 2010-06-07 | 2013-07-04 | Manuel Mayr | Methods and means for predicting or diagnosing diabetes or cardiovascular disorders based on micro rna |
| MX355020B (es) | 2010-07-09 | 2018-04-02 | Somalogic Inc | Biomarcadores de cancer de pulmon y usos de los mismos. |
| JP5931874B2 (ja) | 2010-08-13 | 2016-06-08 | ソマロジック・インコーポレーテッド | 膵癌バイオマーカーおよびその使用 |
| TW201231671A (en) * | 2011-01-28 | 2012-08-01 | Univ Kaohsiung Medical | Method and kit for in vitro diagnosis of atherosclerosis |
| EP2714934B1 (en) * | 2011-05-24 | 2018-09-19 | Rosetta Genomics Ltd | Methods and compositions for determining heart failure or a risk of heart failure |
| US9708643B2 (en) * | 2011-06-17 | 2017-07-18 | Affymetrix, Inc. | Circulating miRNA biomaker signatures |
| CN103988076A (zh) | 2011-08-12 | 2014-08-13 | 阿尔弗雷德医疗集团 | 包括测量巨噬细胞移动抑制因子（mif）的血浆浓度的诊断、预后或治疗急性冠状动脉综合征（acs）的方法 |
| SG10201607331WA (en) * | 2011-09-30 | 2016-11-29 | Somalogic Inc | Cardiovascular risk event prediction and uses thereof |
| WO2013060894A1 (en) * | 2011-10-27 | 2013-05-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment and diagnosis of atherosclerosis |
| CN103103189B (zh) * | 2011-11-14 | 2015-06-03 | 中国科学院上海生命科学研究院 | 过表达单一MicroRNA成熟体序列的新方法 |
| CN103160507B (zh) * | 2011-12-19 | 2017-05-24 | 上海交通大学医学院附属新华医院 | 检测肝硬化的miRNA血清标志物及其应用 |
| ITRM20110685A1 (it) | 2011-12-23 | 2013-06-24 | Internat Ct For Genetic En Gineering And | Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci |
| ES2886979T3 (es) | 2012-02-09 | 2021-12-21 | Memed Diagnostics Ltd | Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos |
| US10417575B2 (en) * | 2012-12-14 | 2019-09-17 | Microsoft Technology Licensing, Llc | Resource allocation for machine learning |
| DE102012101557A1 (de) * | 2012-02-27 | 2013-08-29 | Charité Universitätsmedizin Berlin | Verwendung von microRNAs oder Genen als Marker zur Identifizierung, Diagnose und Therapie einzelner nicht-ischämischer Kardiomyopathien oder Speichererkrankungen des Herzens |
| CN102708384B (zh) * | 2012-06-04 | 2014-01-29 | 西南交通大学 | 一种基于随机蕨的自举弱学习方法及其分类器 |
| US9002769B2 (en) * | 2012-07-03 | 2015-04-07 | Siemens Aktiengesellschaft | Method and system for supporting a clinical diagnosis |
| US9336302B1 (en) | 2012-07-20 | 2016-05-10 | Zuci Realty Llc | Insight and algorithmic clustering for automated synthesis |
| CN102839172B (zh) * | 2012-08-24 | 2013-09-25 | 中国医科大学附属第一医院 | HIV感染疾病进展分子标志物miR-503 |
| US20140087964A1 (en) * | 2012-09-24 | 2014-03-27 | University Of Virginia Patent Foundation | Compositions and methods for detecting aberrant regulation, expression, and levels of hgh |
| US9996889B2 (en) * | 2012-10-01 | 2018-06-12 | International Business Machines Corporation | Identifying group and individual-level risk factors via risk-driven patient stratification |
| CN102980920A (zh) * | 2012-11-14 | 2013-03-20 | 华东师范大学 | 同时检测miRNAs与蛋白标记物的硅纳米线芯片及其检测方法和应用 |
| CN103233007A (zh) * | 2013-02-05 | 2013-08-07 | 中国科学院广州生物医药与健康研究院 | hsa-miR-545miRNA及其应用 |
| CA2903781C (en) * | 2013-03-04 | 2023-08-08 | Board Of Regents Of The University Of Texas System | System and method for determining triage categories |
| CA2907025A1 (en) * | 2013-03-15 | 2014-09-18 | The Hospital For Sick Children | Diagnostic and therapeutic methods relating to microrna-144 |
| CN103205505B (zh) * | 2013-05-03 | 2014-11-05 | 周玲 | 一种诊断妊娠糖尿病的microRNA分子标志物及其检测试剂盒 |
| KR20150007468A (ko) * | 2013-07-11 | 2015-01-21 | (의료)길의료재단 | 임상의사결정 지원방법 및 그 장치 |
| US9953417B2 (en) * | 2013-10-04 | 2018-04-24 | The University Of Manchester | Biomarker method |
| CN104357554B (zh) * | 2013-11-26 | 2016-08-24 | 上海中医药大学附属岳阳中西医结合医院 | 微小核苷酸hsa-miR939在高血压诊断中的应用 |
| CN103642914B (zh) * | 2013-11-29 | 2015-02-25 | 中国人民解放军第四军医大学 | 与恶性黑素瘤相关的血浆/血清循环microRNA标志物及其应用 |
| US10817791B1 (en) * | 2013-12-31 | 2020-10-27 | Google Llc | Systems and methods for guided user actions on a computing device |
| US10138717B1 (en) * | 2014-01-07 | 2018-11-27 | Novi Labs, LLC | Predicting well performance with feature similarity |
| US11145417B2 (en) * | 2014-02-04 | 2021-10-12 | Optimata Ltd. | Method and system for prediction of medical treatment effect |
| EP3117220B1 (en) | 2014-03-12 | 2020-07-08 | Icahn School of Medicine at Mount Sinai | Method for identifying kidney allograft recipients at risk for chronic injury |
| CN104017806B (zh) * | 2014-05-08 | 2017-11-10 | 复旦大学 | microRNA及其在制备活动性结核病检测试剂中的应用 |
| US11017881B2 (en) | 2014-05-15 | 2021-05-25 | Codondex Llc | Systems, methods, and devices for analysis of genetic material |
| WO2015175602A1 (en) | 2014-05-15 | 2015-11-19 | Codondex Llc | Systems, methods, and devices for analysis of genetic material |
| US10308985B2 (en) * | 2014-06-26 | 2019-06-04 | Icahn School Of Medicine At Mount Sinai | Methods for diagnosing risk of renal allograft fibrosis and rejection |
| WO2015200887A2 (en) | 2014-06-26 | 2015-12-30 | Icahn School Of Medicine At Mount Sinai | Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets |
| WO2016007549A1 (en) | 2014-07-07 | 2016-01-14 | Veramarx, Inc. | Biomarker signatures for lyme disease and methods of use thereof |
| EP3180621B1 (en) | 2014-08-14 | 2020-04-01 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| EP3189164B1 (en) * | 2014-09-05 | 2021-11-10 | American University Of Beirut | Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna |
| AU2014407088B2 (en) | 2014-09-26 | 2021-09-23 | Somalogic Operating Co., Inc. | Cardiovascular risk event prediction and uses thereof |
| CN104278105A (zh) * | 2014-11-07 | 2015-01-14 | 雷桅 | 一种检测冠心病的血清学生物标志物miR-19a及其用途 |
| CN111624345A (zh) | 2014-12-11 | 2020-09-04 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| JP6782405B2 (ja) * | 2014-12-15 | 2020-11-11 | 学校法人 久留米大学 | 腎性貧血のバイオマーカーとしての赤血球ａｄｍａの使用 |
| CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| WO2016168336A1 (en) * | 2015-04-14 | 2016-10-20 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions |
| KR101903526B1 (ko) * | 2015-08-19 | 2018-10-05 | 한국전자통신연구원 | 바이오 물질의 농도를 기반으로 하는 질환 예측 장치 및 그것의 질환 예측 방법 |
| DE102015216782B3 (de) * | 2015-09-02 | 2017-01-26 | Ikdt Institut Kardiale Diagnostik Und Therapie Gmbh | Verwendung von im Blutserum oder Blutplasma zirkulierenden microRNAs zur Identifikation biopsiepflichtiger Patienten und als Marker zur Differentialdiagnose einzelner nicht-ischämischer Kardiomyopathien oder Speichererkrankungen des Herzens |
| CN106609301B (zh) * | 2015-10-26 | 2019-10-25 | 北京大学人民医院 | 一种辅助诊断1型糖尿病的试剂盒 |
| US11191490B2 (en) * | 2015-12-02 | 2021-12-07 | Siemens Healthcare Gmbh | Personalized assessment of patients with acute coronary syndrome |
| EA201600076A1 (ru) * | 2015-12-30 | 2017-07-31 | Андрей Владимирович ТИТОВ | Способ оценки состояния организма по образцам биологической жидкости, получаемой неинвазивно |
| WO2017119881A1 (en) * | 2016-01-06 | 2017-07-13 | Veramarx, Inc. | Biomarker signatures for lyme disease differentiation and methods of use thereof |
| EP3196317A1 (en) | 2016-01-21 | 2017-07-26 | Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Predictive methods of atherosclerosis and stenosis |
| FR3047013A1 (fr) * | 2016-01-22 | 2017-07-28 | Univ Montpellier | Procede de classification d'un echantillon biologique. |
| CN105486878B (zh) * | 2016-01-22 | 2018-02-06 | 徐超 | 一种临床个体化组合用药的筛选系统及其方法 |
| CN105445408B (zh) * | 2016-01-25 | 2018-06-12 | 齐炼文 | 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物 |
| CN107194138B (zh) * | 2016-01-31 | 2023-05-16 | 北京万灵盘古科技有限公司 | 一种基于体检数据建模的空腹血糖预测方法 |
| WO2017136464A1 (en) | 2016-02-01 | 2017-08-10 | Prevencio, Inc. | Diagnostic and prognostic methods for cardiovascular diseases and events |
| IL287757B (en) | 2016-03-03 | 2022-07-01 | Memed Diagnostics Ltd | Analyzing rna for diagnosing infection type |
| CN105713972A (zh) * | 2016-03-16 | 2016-06-29 | 上海中医药大学 | miRNA在制备药物性心脏病生物标志物中的用途 |
| ES2968349T3 (es) | 2016-03-31 | 2024-05-09 | Abbott Lab | Sistemas basados en árboles de decisión y métodos para estimar el riesgo de síndrome coronario agudo |
| CN109804245B (zh) | 2016-07-10 | 2022-10-25 | 米密德诊断学有限公司 | 感染的早期诊断 |
| EP4141448A1 (en) * | 2016-07-10 | 2023-03-01 | MeMed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
| US20180166170A1 (en) * | 2016-12-12 | 2018-06-14 | Konstantinos Theofilatos | Generalized computational framework and system for integrative prediction of biomarkers |
| AU2018205825A1 (en) * | 2017-01-06 | 2019-08-15 | Codondex Llc | Systems, methods, and devices for analysis of genetic material |
| EP3574318B1 (en) * | 2017-01-27 | 2020-12-09 | Becton, Dickinson and Company | Vertical flow assay device for detecting glucose concentration in a fluid sample |
| EP3647422B1 (en) * | 2017-06-29 | 2024-07-24 | Toray Industries, Inc. | Kit, device, and method for lung cancer detection |
| TWI641963B (zh) * | 2017-07-07 | 2018-11-21 | 長庚醫療財團法人林口長庚紀念醫院 | Method for screening coronary heart disease by cardiovascular marker and mechanical learning algorithm |
| CN111279194A (zh) | 2017-09-30 | 2020-06-12 | 阿尔佛雷德医疗集团 | 预后方法 |
| CA3081752A1 (en) * | 2017-11-02 | 2019-05-09 | Prevencio, Inc. | Diagnostic and prognostic methods for peripheral arterial diseases, aortic stenosis, and outcomes |
| CN113116918B (zh) * | 2017-12-29 | 2022-06-14 | 中国科学院上海药物研究所 | 靶向PCSK9的microRNA在治疗LDLC相关代谢性疾病中的应用 |
| CN108004316A (zh) * | 2018-01-09 | 2018-05-08 | 青岛大学 | 用于预测急性心肌梗死风险的试剂盒 |
| CN108376564A (zh) * | 2018-02-06 | 2018-08-07 | 天津艾登科技有限公司 | 基于随机森林算法的疾病诊断并发症识别方法及系统 |
| CN108070650B (zh) * | 2018-02-09 | 2021-02-12 | 深圳承启生物科技有限公司 | 外泌体中microRNA在诊断缺血性脑卒中疾病的用途 |
| US10915729B2 (en) * | 2018-02-20 | 2021-02-09 | The Regents Of The University Of Michigan | Three-dimensional cell and tissue image analysis for cellular and sub-cellular morphological modeling and classification |
| CN108492272B (zh) * | 2018-03-26 | 2021-01-19 | 西安交通大学 | 基于注意力模型及多任务神经网络的心血管易损斑块识别方法及系统 |
| WO2019204267A1 (en) | 2018-04-16 | 2019-10-24 | Icahn School Of Medicine At Mount Sinai | Method and kits for prediction of acute rejection and renal allograft loss using pre-transplant transcriptomic signatures in recipient blood |
| WO2019217714A1 (en) * | 2018-05-09 | 2019-11-14 | The General Hospital Corporation | Determination and reduction of risk of sudden cardiac death |
| RU2677280C1 (ru) * | 2018-05-17 | 2019-01-16 | федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ диагностики многососудистого атеросклеротического поражения коронарных артерий у больных ишемической болезнью сердца при абдоминальном ожирении |
| CN108728437A (zh) * | 2018-05-25 | 2018-11-02 | 中国人民解放军陆军军医大学 | 促进骨骼肌损伤修复的寡核苷酸、药物及应用 |
| US12292451B2 (en) * | 2018-06-08 | 2025-05-06 | Cleveland Clinic Foundation | ApoA1 exchange rate assays in serum |
| CN108803994B (zh) * | 2018-06-14 | 2022-10-14 | 四川和生视界医药技术开发有限公司 | 视网膜血管的管理方法及视网膜血管的管理装置 |
| CN109009222A (zh) * | 2018-06-19 | 2018-12-18 | 杨成伟 | 面向心脏病类型和严重程度的智能评估诊断方法及系统 |
| CN108796070B (zh) * | 2018-07-16 | 2022-09-30 | 辽宁中医药大学 | miR-125a-3p在制备心血管疾病诊断试剂盒中的用途 |
| CN108998514B (zh) * | 2018-08-20 | 2022-02-01 | 青岛大学 | miRNA-378及其抑制剂的应用和应用其的产品 |
| CN109411015B (zh) * | 2018-09-28 | 2020-12-22 | 深圳裕策生物科技有限公司 | 基于循环肿瘤dna的肿瘤突变负荷检测装置及存储介质 |
| US11103171B2 (en) * | 2018-10-23 | 2021-08-31 | BlackThor Therapeutics, Ine. | Systems and methods for screening, diagnosing, and stratifying patients |
| US11928985B2 (en) * | 2018-10-30 | 2024-03-12 | International Business Machines Corporation | Content pre-personalization using biometric data |
| KR102165841B1 (ko) * | 2018-11-05 | 2020-10-14 | 순천향대학교 산학협력단 | 당뇨병 진단을 위한 마이크로RNA let-7b 또는 마이크로RNA-664a 바이오마커 및 이의 용도 |
| EP3886696A4 (en) * | 2018-11-29 | 2022-08-24 | SomaLogic Operating Co., Inc. | Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis |
| CN110229893A (zh) * | 2019-02-04 | 2019-09-13 | 金华市中心医院 | 用于诊断颈动脉粥样硬化斑块的miRNAs标志物及其应用 |
| CN110082536B (zh) * | 2019-04-17 | 2022-06-10 | 广州医科大学附属肿瘤医院 | 一种乳腺癌细胞标志物细胞因子群及其应用 |
| US11030743B2 (en) * | 2019-05-16 | 2021-06-08 | Tencent America LLC | System and method for coronary calcium deposits detection and labeling |
| WO2020260554A1 (en) * | 2019-06-26 | 2020-12-30 | Westfälische Wilhelms-Universität Münster | Method for establishing an individual physical activity program for a subject for reducing an individual risk of the subject for developing a cardiovascular disease |
| CN111154870B (zh) * | 2019-08-05 | 2023-06-23 | 江苏省肿瘤医院 | 一种鼻咽癌转移诊断和/或预后评估的生物标记 |
| CA3153506A1 (en) * | 2019-10-02 | 2021-04-08 | Diego Ariel Rey | Biomarker panels for guiding dysregulated host response therapy |
| CA3156785A1 (en) * | 2019-11-04 | 2021-05-14 | Oxford University Innovation Limited | Identification and characterisation of herbicides and plant growth regulators |
| CN111275125A (zh) * | 2020-02-10 | 2020-06-12 | 东华大学 | 一种面向低秩图像特征分析的类别标签恢复方法 |
| US11058710B1 (en) | 2020-02-14 | 2021-07-13 | Dasman Diabetes Institute | MicroRNA ANGPTL3 inhibitor |
| CN111718991A (zh) * | 2020-07-03 | 2020-09-29 | 西安交通大学医学院第一附属医院 | 血浆miRNA分子标志物在诊断代谢综合征中的应用 |
| CN114058696B (zh) * | 2020-07-29 | 2023-08-18 | 四川大学华西医院 | miR-519e-5p作为甲状腺乳头状癌远处转移检测或治疗靶点中的用途 |
| CN114113624B (zh) * | 2020-08-28 | 2024-08-16 | 香港城市大学深圳研究院 | 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置 |
| EP3971909A1 (en) * | 2020-09-21 | 2022-03-23 | Thorsten Kaiser | Method for predicting markers which are characteristic for at least one medical sample and/or for a patient |
| CN112280845A (zh) * | 2020-09-22 | 2021-01-29 | 山东大学第二医院 | miR-328-3p在制备脑梗死及脑缺血再灌注预后预测试剂中的应用 |
| CN114520054A (zh) * | 2020-11-18 | 2022-05-20 | 英业达科技有限公司 | 心衰竭预测组件及心衰竭预测方法 |
| CN112530595A (zh) * | 2020-12-21 | 2021-03-19 | 无锡市第二人民医院 | 一种基于多分支链式神经网络的心血管疾病分类方法和装置 |
| CN112680509A (zh) * | 2021-01-20 | 2021-04-20 | 河南省中医院（河南中医药大学第二附属医院） | 一种评估冠心病预后分子标志物miR-302e及其逆转录引物、扩增引物和应用 |
| CN112904020A (zh) * | 2021-01-25 | 2021-06-04 | 上海市第六人民医院 | Fam172a在筛查和治疗糖尿病大血管病变中的应用 |
| CN112509700A (zh) * | 2021-02-05 | 2021-03-16 | 中国医学科学院阜外医院 | 稳定型冠心病的风险预测方法及装置 |
| CN112941167A (zh) * | 2021-03-16 | 2021-06-11 | 宁夏医科大学 | 一种心血管疾病诊断用miRNA标志物及其应用 |
| EP4326894A4 (en) * | 2021-04-24 | 2025-06-04 | University of Notre Dame du Lac | Method and device for detection of myocardial infarction and reperfusion injury |
| CN113293207B (zh) * | 2021-06-22 | 2022-09-02 | 上海市东方医院（同济大学附属东方医院） | 外周血miRNA在制备作为心衰诊断或者预后的生物标志物中的用途 |
| JP2024535756A (ja) * | 2021-09-07 | 2024-10-02 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | バイオマーカー組成物およびその使用方法 |
| CN113943792A (zh) * | 2021-11-02 | 2022-01-18 | 石河子大学 | 检测miRNA表达量的试剂在制备诊断或预后哈萨克族高血压的试剂或试剂盒中的应用 |
| CN115901901A (zh) * | 2022-01-15 | 2023-04-04 | 山东师范大学 | TiO2-MoO3纳米阵列及基于其的miR-145-3p早检传感芯片及其应用 |
| CN114388121B (zh) * | 2022-03-25 | 2022-06-03 | 北京盛坤康如医疗器械有限责任公司 | 心脏标志物poct系统及医疗器材 |
| EP4533484A1 (en) * | 2022-06-03 | 2025-04-09 | Foundation Medicine, Inc. | Methods and systems for classification of disease entities via mixture modeling |
| CN114990229B (zh) * | 2022-06-20 | 2023-01-03 | 广东医科大学附属医院 | 一种嗜碱性粒细胞活化相关的生物标志物及其应用 |
| CN116334206A (zh) * | 2022-11-09 | 2023-06-27 | 上海长征医院 | miR-541在制备肝纤维化/肝硬化无创诊断及预后评估试剂盒中的应用 |
| KR20250031367A (ko) * | 2023-08-28 | 2025-03-07 | 고려대학교 산학협력단 | 동맥경화증 진단용 엑소좀 유래 바이오 마커 |
| WO2025135469A1 (ko) * | 2023-12-22 | 2025-06-26 | 서울대학교병원 | 대사질환 예측 또는 진단을 위한 마이크로 rna 바이오마커 및 이의 용도 |
| CN117737262A (zh) * | 2024-02-21 | 2024-03-22 | 山东第一医科大学(山东省医学科学院) | 一种miRNA标志物在制备鉴别体液斑产品中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6059724A (en) * | 1997-02-14 | 2000-05-09 | Biosignal, Inc. | System for predicting future health |
| US7888497B2 (en) * | 2003-08-13 | 2011-02-15 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof |
| US7306562B1 (en) * | 2004-04-23 | 2007-12-11 | Medical Software, Llc | Medical risk assessment method and program product |
| US7635563B2 (en) * | 2004-06-30 | 2009-12-22 | Massachusetts Institute Of Technology | High throughput methods relating to microRNA expression analysis |
| US20070099239A1 (en) * | 2005-06-24 | 2007-05-03 | Raymond Tabibiazar | Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| WO2008043521A2 (de) * | 2006-10-09 | 2008-04-17 | Julius-Maximilians-Universität Würzburg | Microrna (mirna) zur diagnose und therapie von herzerkrankungen |
| SG177948A1 (en) * | 2006-10-19 | 2012-02-28 | Entelos Inc | Method and apparatus for modeling atherosclerosis |
| WO2008080126A2 (en) * | 2006-12-22 | 2008-07-03 | Aviir, Inc. | Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| US8768718B2 (en) * | 2006-12-27 | 2014-07-01 | Cardiac Pacemakers, Inc. | Between-patient comparisons for risk stratification of future heart failure decompensation |
| US20090156906A1 (en) * | 2007-06-25 | 2009-06-18 | Liebman Michael N | Patient-centric data model for research and clinical applications |
| KR20100049079A (ko) * | 2007-07-18 | 2010-05-11 | 더 리젠트스 오브 더 유니버시티 오브 콜로라도 | 인간의 정상 심장과 기능부진 심장에서 마이크로 ｒｎａ의 차등 발현 |
| US20110160285A1 (en) * | 2008-03-13 | 2011-06-30 | The Regents Of The University Of Colorado | Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy |
| SG177938A1 (en) * | 2008-03-26 | 2012-02-28 | Theranos Inc | Methods and systems for assessing clinical outcomes |
| US8224665B2 (en) * | 2008-06-26 | 2012-07-17 | Archimedes, Inc. | Estimating healthcare outcomes for individuals |
-
2010
- 2010-12-09 WO PCT/US2010/059781 patent/WO2011072177A2/en not_active Ceased
- 2010-12-09 JP JP2012543298A patent/JP2013513387A/ja active Pending
- 2010-12-09 US US12/964,719 patent/US20110144914A1/en not_active Abandoned
- 2010-12-09 AU AU2010328019A patent/AU2010328019A1/en not_active Abandoned
- 2010-12-09 CA CA2783536A patent/CA2783536A1/en not_active Abandoned
- 2010-12-09 CN CN2010800635211A patent/CN102762743A/zh active Pending
- 2010-12-09 EP EP10791032A patent/EP2510116A2/en not_active Withdrawn
-
2015
- 2015-07-01 US US14/788,828 patent/US20150376704A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013513387A5 (enExample) | ||
| Jylhävä et al. | Biological age predictors | |
| Wu et al. | Circulating microRNAs as biomarkers of Alzheimer’s disease: a systematic review | |
| Wang et al. | Analysis of serum microRNA profile by solexa sequencing in women with endometriosis | |
| Wermuth et al. | Existing and novel biomarkers for precision medicine in systemic sclerosis | |
| Jiao et al. | Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy | |
| US20120178118A1 (en) | Biomarkers for monitoring treatment of neuropsychiatric diseases | |
| Vliegenthart et al. | MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury | |
| CN102257157A (zh) | 人抑郁症的生物标记超映射 | |
| Wei et al. | Point-of-care devices using disease biomarkers to diagnose neurodegenerative disorders | |
| Zhang et al. | A strategy for the development of biomarker tests for PTSD | |
| Paczkowska-Abdulsalam et al. | Evaluation of transcriptomic regulations behind metabolic syndrome in obese and lean subjects | |
| Szabo et al. | Transcriptomic biomarkers in safety and risk assessment of chemicals | |
| Teixeira dos Santos et al. | Recent developments in circulating biomarkers in Parkinson’s disease: the potential use of miRNAs in a clinical setting | |
| Chen et al. | Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged | |
| Jaber et al. | Precision medicine in depression: the role of proteomics and metabolomics in personalized treatment approaches | |
| Gorla et al. | Increase of circulating endothelial progenitor cells and released angiogenic factors in children with moyamoya arteriopathy | |
| JP6010848B2 (ja) | ストレスの評価方法、ストレス評価マーカー、ストレス負荷モデル動物の作成方法、及びストレス負荷モデル動物 | |
| Trumpff et al. | Blood mitochondrial health markers cf-mtDNA and GDF15 in human aging | |
| Jang et al. | Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review | |
| CN117969851A (zh) | 一种基于Olink蛋白质组学的缺血性脑卒中免疫应答相关早筛标志物及其选择方法和应用 | |
| CN118374598A (zh) | 一种用于脑动脉瘤破裂早期诊断或检测的rna甲基化相关炎症基因标记物及其应用 | |
| Yu et al. | Exploring potential biomarkers for acute myocardial infarction by combining circadian rhythm gene expression and immune cell infiltration | |
| Liu et al. | Association between CLPTM1L–TERT rs401681 polymorphism and risk of pancreatic cancer: a meta-analysis | |
| Teixeira et al. | Gut feeling: Biomarkers and biosensors’ potential in revolutionizing inflammatory bowel disease (IBD) diagnosis and prognosis—A comprehensive review |